The relevance of cytokines for development of protective immunity and rational design of vaccines

被引:62
作者
Chabalgoity, Jose A.
Baz, Adriana
Rial, Analia
Grille, Sofia
机构
[1] Univ Republica, Fac Med, Dept Desarrollo Biotecnol, Lab Vaccine Res, Montevideo 11600, Uruguay
[2] Univ Republica, Sch Chem, Dept Immunol, Montevideo 11600, Uruguay
[3] Univ Republica, Sch Sci, Montevideo 11600, Uruguay
[4] Queensland Inst Med Res, Div Infect Dis & Immunol, Immunoregulat Lab, Brisbane, Qld 4006, Australia
[5] Univ Republica, Fac Med, Hosp Clin, Dept Basico Med, Montevideo 11600, Uruguay
基金
美国国家卫生研究院; 英国惠康基金;
关键词
cytokines; immunity; vaccines; T cell;
D O I
10.1016/j.cytogfr.2007.01.016
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytokines are key regulators of the immune system that shape innate and adaptive immune responses. An adequate balance of the cytokine environment is critical to achieve protective immunity and to avoid immunopathology. Present knowledge allows a deeper understanding of the cytokine network and their sometimes conflicting roles in the development of immune responses, as well as their relevance in the establishment and maintenance of immunological memory. New insights have been gained into the role of different T cell subsets for protection against infection or tumor growth. The incorporation of cytokines as molecular adjuvants in vaccines has been attempted to strengthen vaccine-induced immune responses, and as a rational approach to modulate cytokine milieu in vivo and tailor host immunity for specific situations. These approaches have been tried in experimental models and veterinary species, and a few of them have entered into clinical trials. However, manipulating the cytokine network to modulate immune responses is not a simple task, because cytokine functions are complex and the final effects on the immune response will depend on timing and length of exposure, cell(s) targeted and other cytokines present in the same microenvironment. Here, we will review our present understanding on the role of cytokines in the development of effector and memory T cell responses. Also the potential use of cytokines as molecular adjuvant for vaccines against infectious diseases and cancer will be revised. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:195 / 207
页数:13
相关论文
共 125 条
[1]   Immunomodulation of cancer: potential use of selectively replicating agents [J].
Agha-Mohammadi, S ;
Lotze, MT .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (09) :1173-1176
[2]   Mechanisms of cytokine synergy essential for vaccine protection against viral challenge [J].
Ahlers, JD ;
Belyakov, IM ;
Matsui, S ;
Berzofsky, JA .
INTERNATIONAL IMMUNOLOGY, 2001, 13 (07) :897-908
[3]   Cutting edge: CD8 T cells specific for lymphocytic choriomeningitis virus require type IIFN receptor for clonal expansion [J].
Aichele, P ;
Unsoeld, H ;
Koschella, M ;
Schweier, O ;
Kalinke, U ;
Vucikuja, S .
JOURNAL OF IMMUNOLOGY, 2006, 176 (08) :4525-4529
[4]   Vaccine-induced immunity against Helicobacter pylori infection is impaired in IL-18-deficient mice [J].
Akhiani, AA ;
Schön, K ;
Lycke, N .
JOURNAL OF IMMUNOLOGY, 2004, 173 (05) :3348-3356
[5]   Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells [J].
Akhiani, AA ;
Pappo, J ;
Kabok, Z ;
Schön, K ;
Gao, W ;
Franzén, LE ;
Lycke, N .
JOURNAL OF IMMUNOLOGY, 2002, 169 (12) :6977-6984
[6]   Cytokine-based therapy and biochemotherapy for advanced melanoma [J].
Atkins, MB .
CLINICAL CANCER RESEARCH, 2006, 12 (07) :2353S-2358S
[7]  
AVERIL M, 2006, ANNU REV IMMUNOL, V24, P657
[8]   CD8+ T cell contraction is controlled by early inflammation [J].
Badovinac, VP ;
Porter, BB ;
Harty, JT .
NATURE IMMUNOLOGY, 2004, 5 (08) :809-817
[9]   Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype [J].
Bamford, KB ;
Fan, XJ ;
Crowe, SE ;
Leary, JF ;
Gourley, WK ;
Luthra, GK ;
Brooks, EG ;
Graham, DY ;
Reyes, VE ;
Ernst, PB .
GASTROENTEROLOGY, 1998, 114 (03) :482-492
[10]   THE INTERLEUKIN (IL)-2 RECEPTOR-BETA CHAIN IS SHARED BY IL-2 AND A CYTOKINE, PROVISIONALLY DESIGNATED IL-T, THAT STIMULATES T-CELL PROLIFERATION AND THE INDUCTION OF LYMPHOKINE-ACTIVATED KILLER-CELLS [J].
BAMFORD, RN ;
GRANT, AJ ;
BURTON, JD ;
PETERS, C ;
KURYS, G ;
GOLDMAN, CK ;
BRENNAN, J ;
ROESSLER, E ;
WALDMANN, TA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (11) :4940-4944